Skip to main content

Funding opportunities

This page contains a list of current funding opportunities offered by other societies, associations and organisations.  If you would like to advertise a funding opportunity on this page, please contact our Education & Careers Officer, Eolan Healy.

Funding opportunities are removed once the application deadline has passed.

You may also find it useful to have a look at our jobs board. In addition to the specific opportunities below, the following websites contain information on sources of funding.

For information relating to funding postgraduate courses and research in the UK:

For information on research funding and fellowship opportunities at all levels in the UK and internationally:

Funding Opportunities

EFIS IL Short Term Fellowship

The European Federation of Immunological Societies (EFIS) and Immunology Letters (IL) award short-term fellowships for up to 3 months of support for purposes of transnational scientific collaboration or advanced training in techniques or methodologies. The EFIS-IL Short-term Fellowship allowance is € 1.750/month and is awarded directly to the fellowship holder. In addition, EFIS will reimburse travel costs up to € 500. Members of the British Society for Immunology are eligible to apply for this award. Applicants must be 35 years or younger and hold at least a Masters degree. Full information is available on the EFIS website

Closing Date:
Tackling multimorbidity at scale: Understanding disease clusters, determinants & biological pathways

Multimorbidity is associated with a reduction in quality of life, increased use of health services and reduced life expectancy. As the number of conditions an individual has increases, so does the likelihood of increased healthcare costs. Multimorbidity has suffered scientifically from being seen as a random assortment of diseases, making it difficult to address. However, with new understanding of the impact of various factors (including biological, social, behavioural, environmental and others), multimorbidity can be seen as series of non-random clusters of disease.

This will require new multi-disciplinary approaches to mapping and tackling multimorbidity, at scale.

To this end there is:

A Strategic Priorities Fund (SPF) research call, jointly funded by the UK Research and Innovation (UKRI) and the Department of Health and Social Care (DHSC) through the National Institute for Health Research (NIHR), will bring together multi-disciplinary collaborations with a range of scientific, methodological, and clinical knowledge and skills to build manageable, focussed “Multimorbidity Research Collaboratives”. These collaboratives will be expected to have strong patient involvement, as benefits the remit of the project, and add significant understanding to a broad range of topics including, for example:

  • Identification of new disease clusters
  • Multimorbidity over different stages across the life-course taking a comprehensive multi- disciplinary approach
  • Discovery, validation and targeting of underlying mechanistic and pathobiological pathways
  • Recognising the potential to identify new patterns of multimorbidity and contributing factors, and the more advanced nature of research on more established multimorbidity clusters, the call is designed in two streams.

For those groups that need time to consolidate existing data or collaborations and/or obtain preliminary data there is an option to apply for a rapid and modest “Consolidator grant”. These grants will serve as a test bed, bringing new disciplines together and provide proof-of-concept data, enabling the best groupings and ideas to mature to a second “Research Collaborative award” stage.
For those other groups that have already developed multi-disciplinary networks and supporting data, there will be the option to move straight to the “Research Collaborative award” stage.

Consolidator grant:

Up to £1.5 million is available for Consolidator grants. These will be funded for the fixed duration of 6 months; the award amount will be up to £100,000 (RC contribution). All awards are expected to be collaborative and multi-disciplinary in nature. Research teams may build on existing relationships or develop a new collaboration between different researchers and/or resources, for instance, grouping of investigators with single disease expertise branching out to extend their work through newly established links with scientists working on different diseases, methodologists, statisticians, researchers from other disciplines, carers and patient groups.

Research Collaborative award:

Research groups with more mature collaboration links; ownership or existing access to the relevant datasets; and sufficient evidence, underpinned by strong preliminary data, of their ability to perform multimorbidity research at scale, can apply for the Wave 1 Research Collaborative awards, bypassing Consolidator stage. These awards will provide substantial investment to support ambitious studies performed by combinations of partners. Research Collaboratives may include, where appropriate, industry partners, in which case they would require to submit their application as a MRC Industry Collaboration Agreement (please read about the MRC Policy on academic-industry collaborations here). This competition seeks to support a balanced research portfolio of several Research Collaboratives for 2-4 years (£3-5m each).

Closing Date:
Medical Research Council
Alopecia UK Research funding call 2020

Alopecia UK is inviting applications for our 2020 research funding call. The intention of the Alopecia UK research funding call is to further alopecia research in the UK.  The charity’s overall research aim is to provide hope and confidence to people with alopecia by funding research into its causes, with the aim of finding treatments, and ultimately, a cure.

We offer a range of funding opportunities. Find out about them, and how to make an application, below.

Funding Opportunities Available:
Research pots (up to £10,000): for research into all types of alopecia
Small grants (up to £1,500): these grants will be aimed at research students and early career researchers
A patient and public involvement grant (up to £500): for researchers who want to involve those affected by alopecia in designing or disseminating research projects.

Additional notes: 

  • These funding schemes are available to anybody wishing to carry out research into alopecia.
  • Only one project to be submitted per person per grant round.
  • Not more than 50% of the grant to be used on buying equipment.
Closing Date:
Alopecia UK
Cancer, tuberculosis and vaccines in new IMI Call for proposals

The Innovative Medicines Initiative (IMI) is launching a new Call for proposals with funding opportunities in cancer, tuberculosis, vaccines, psoriatic arthritis and drugs based on proteins. IMI2 – Call 20 has a total budget of EUR 273 million. IMI will contribute EUR 133 million to the projects funded under the Call; these funds come from Horizon 2020 and will support the participation in the projects of organisations such as universities, small and medium-sized enterprises, and patient groups. EFPIA companies and IMI Associated Partners will contribute EUR 140 million, mostly as ‘in kind' contributions (e.g. staff time, access to equipment, etc.).


  • Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
  • Topic 2: Innovations to accelerate vaccine development and manufacture
  • Topic 3: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
  • This topic is part of the IMI AMR Accelerator Programme. Applicants should also read the Questions and Answers on the programme (document last updated November 2019).
  • Topic 4: Tumour plasticity
  • Topic 5: Proton versus photon therapy for oesophageal cancer – a trimodality strategy
  • Topic 6: Handling of protein drug products and stability concerns

Key dates and deadlines

  • Draft topic texts published: 15 October 2019
  • Publication date: 21 January 2020
  • Stage 1 submission start date: 21 January 2020
  • Stage 1 submission deadline: 21 April 2020
  • Stage 2 submission deadline: 5 November 2020


Closing Date:
Future Leaders Fellowships

Future Leaders Fellowships will grow the strong supply of talented individuals needed to ensure a vibrant environment for research and innovation in the UK. The scheme is open to researchers and innovators from across business, universities, and other organisations. We welcome applicants from around the world.

Investment of up to £1.2 million over four years, with the ability to extend to up to seven years, will enable the next generation to benefit from outstanding support to develop their careers, and to work on difficult and novel challenges.

UKRI want to fund the best fellows no matter what their background. The Future Leaders Fellowships scheme has been developed with unprecedented levels of flexibility to support applicants from a wide range of experiences, disciplines and sectors.

Round 5 for the Fellowships is now open. Applicants must apply to the scheme with the support of their host organisation.

Outline proposal
Outline proposals are mandatory for each applicant intending to submit to Round 5 of this scheme. The deadline for receiving these is 16:00 on 30 April 2020.

  • Applicants in host organisations that are not registered with Je-S (for example, businesses that have not previously applied for a grant from a research council) can submit their outline proposal through an online form. You will still need to register with Je-S later if you wish to proceed and submit a full application.
  • Applicants in host organisations that are already registered with Je-S (universities, research organisations and some businesses) will need to submit their outline proposal through that grant management system. You should ensure sufficient time to create Je-S accounts for both the fellow and any co-investigators.

The outline proposal will need to cover basic details about the proposal, including any co-investigators and project partners, a summary of the proposed fellowship and other information as appropriate. 

Full application
Full applications for Round 5 must be submitted by all organisations via Je-S by 16:00 on 2 June 2020.

If you submit an outline proposal via the web form, you will need to create an account on Je-S in order to submit a full application. You should allow sufficient time to do this.

Closing Date:
GUTS UK: Grants & Awards

GUTS UK are pleased to announce some new and varied research funding opportunities: 

  • GUTS UK/BSG trainee reserach awards
  • GUTS UK development grants
  • GUTS UK nutrition development grants
  • GUTS UK/FORCROHNS development grants
  • The GUTS UK Derek Butler Fellowship
  • GUTS UK Amelie Waring Fellowship
  • GUTS UK/BSPGHAN grants
  • Olympus/GUTS UK Fellowship
  • Parabola/ GUTS UK colorectal cancer research grant
  • GUTS UK/ DR FALK awards
Closing Date:
BMA Foundation for Medical Research – grant categories 2019

All the BMA Foundation for Medical Research grants have National Institute for Health Research (NIHR) partnership status.

Closing Date:
British Medical Association
Medical Research Council (MRC) - variety of fellowships, career development awards and research grants

A variety of fellowships, career development awards and research grants opportunities offered by the Medical Research Council.

Closing Date:
Medical Research Council
Cancer Research UK-MedImmune Alliance Laboratory

Novel, collaborative antibody discovery to accelerate delivery of therapies and diagnostics for cancer patients 

Our laboratory brings together Cancer Research UK’s cancer biology expertise with the world-class antibody engineering technology of MedImmune, the global biologics research and development arm of AstraZeneca, to accelerate antibody discovery

Closing Date:
Cancer Research UK
Various CRUK funding schemes

Cancer Research UK offer a variety of funding opportunities focusing on numerous different areas of research. 

Closing Date:
Cancer Research UK